Japanese Startup Craif Raises $22M to Expand MicroRNA-Based Cancer Detection Technology

Craif, a Japanese startup, secures $22 million in Series C funding to develop miSignal, its microRNA-based early cancer detection software, aiming to enable early cancer detection, even at Stage 1, and plans to broaden its product to include ten different types of cancers.